Tuberculosis of digestive tract organs, not elsewhere classified
ICD-10 A18.83 is a billable code used to indicate a diagnosis of tuberculosis of digestive tract organs, not elsewhere classified.
Tuberculosis (TB) of the digestive tract is a rare form of extrapulmonary tuberculosis that primarily affects the gastrointestinal system, including the esophagus, stomach, intestines, and peritoneum. It occurs when Mycobacterium tuberculosis spreads from the lungs or other infected sites to the digestive organs. Symptoms may include abdominal pain, weight loss, diarrhea, and malabsorption. Diagnosis typically involves a combination of clinical evaluation, imaging studies such as abdominal X-rays or CT scans, and microbiological tests including stool cultures and biopsy of affected tissues. Treatment usually consists of a multi-drug regimen similar to that used for pulmonary TB, often requiring a prolonged course of antibiotics to ensure eradication of the bacteria. Monitoring for drug resistance is crucial, as strains of TB can develop resistance to standard treatments, complicating management. Public health implications are significant, as TB is a contagious disease, necessitating contact tracing and isolation procedures for infected individuals to prevent further transmission.
Detailed patient history, diagnostic test results, treatment plans, and follow-up care.
Patients presenting with gastrointestinal symptoms and a history of TB exposure.
Consideration of drug resistance patterns and the need for specialized treatment regimens.
Endoscopic findings, biopsy results, and imaging studies.
Patients with unexplained abdominal pain and weight loss, particularly in endemic areas.
Differentiating TB from other gastrointestinal diseases such as Crohn's disease or malignancies.
Used when imaging is required to assess for TB involvement in the digestive tract.
Radiology reports and clinical notes indicating the need for imaging.
Radiologists should be aware of TB history when interpreting results.
Common symptoms include abdominal pain, weight loss, diarrhea, and malabsorption. Patients may also experience fever and night sweats.
Diagnosis typically involves a combination of clinical evaluation, imaging studies, and microbiological tests such as stool cultures and biopsies.
Treatment usually involves a multi-drug regimen similar to that for pulmonary TB, often requiring a prolonged course of antibiotics.
TB is a contagious disease, necessitating contact tracing and isolation procedures for infected individuals to prevent further transmission.
